Suppr超能文献

用于常规甲状腺功能检测的促甲状腺激素和游离甲状腺素检测的替代序列。质量与成本。

Alternative sequences of thyrotropin and free thyroxine assays for routine thyroid function testing. Quality and cost.

作者信息

Nordyke R A, Reppun T S, Madanay L D, Woods J C, Goldstein A P, Miyamoto L A

机构信息

Department of Nuclear Medicine, Straub Clinic and Hospital, Inc., Honolulu, USA.

出版信息

Arch Intern Med. 1998 Feb 9;158(3):266-72. doi: 10.1001/archinte.158.3.266.

Abstract

BACKGROUND

Current guidelines and practices for thyroid function testing are strongly affected by the usually higher patient billing charges and Medicare reimbursement for thyrotropin (TSH) vs free thyroxine (FT4) tests, despite their comparable direct costs.

OBJECTIVE

Due to recently reduced laboratory costs, to reexamine the effectiveness and cost of alternative test sequences.

METHODS

Alternative test sequences involve using the TSH test first, followed, if the TSH test result is abnormal, by the FT4 test; the FT4 test first, followed by the TSH test; and doing both tests together. We applied these strategies to consecutive patients referred for any thyroid function test to a health maintenance organization, a multispecialty fee-for-service group, a military hospital, and a commercial laboratory. Effectiveness was determined from a literature review. The cost was determined from direct costs and the distribution of diagnostic categories.

RESULTS

The TSH and FT4 tests have similar sensitivities for detecting clinical hyperthyroidism and hypothyroidism. The TSH test detects subclinical function, and it monitors thyroxine treatment better; the FT4 test detects central hypothyroidism, and it monitors rapidly changing function better. Direct costs for both were equal, but charges for the TSH test were higher. The average direct cost per patient, starting with the FT4 test, was $4.61; starting with the TSH test, $5.90; and starting with both tests together, $6.50. Medicare reimbursements correlated poorly with costs.

CONCLUSIONS

Starting with the TSH test and reflexing to the FT4 test provides a better first-line all-purpose sequence than the reverse. In managed care settings, the slightly higher direct cost of this approach is offset by greater clinical effectiveness. In fee-for-service settings, cost differences can be nearly eliminated by equalizing TSH and FT4 charges to reflect current direct-cost realities. Obtaining both tests together overcomes the disadvantages of each at a slightly higher direct cost.

摘要

背景

目前甲状腺功能检测的指南和实践受到促甲状腺激素(TSH)检测与游离甲状腺素(FT4)检测相比通常更高的患者计费费用和医疗保险报销的强烈影响,尽管它们的直接成本相当。

目的

由于最近实验室成本降低,重新审视替代检测顺序的有效性和成本。

方法

替代检测顺序包括先进行TSH检测,如果TSH检测结果异常,则接着进行FT4检测;先进行FT4检测,然后进行TSH检测;以及同时进行两项检测。我们将这些策略应用于转诊至健康维护组织、多专科按服务收费组、军事医院和商业实验室进行任何甲状腺功能检测的连续患者。有效性通过文献综述确定。成本由直接成本和诊断类别分布确定。

结果

TSH和FT4检测在检测临床甲亢和甲减方面具有相似的敏感性。TSH检测可检测亚临床功能,并且能更好地监测甲状腺素治疗;FT4检测可检测中枢性甲减,并且能更好地监测快速变化的功能。两者的直接成本相等,但TSH检测的收费更高。从FT4检测开始,每位患者的平均直接成本为4.61美元;从TSH检测开始,为5.90美元;同时进行两项检测开始,则为6.50美元。医疗保险报销与成本的相关性较差。

结论

先进行TSH检测然后根据结果进行FT4检测比相反顺序提供了更好的一线通用检测顺序。在管理式医疗环境中,这种方法略高的直接成本被更高的临床有效性所抵消。在按服务收费的环境中,通过使TSH和FT4收费相等以反映当前的直接成本现实,成本差异几乎可以消除。同时进行两项检测以略高的直接成本克服了各自的缺点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验